8-KOther Events

PFIZER INC 8-K Report (Dec 2, 2003)

Filed December 2, 2003For Securities:PFE

Summary

Pfizer Inc. (PFE) filed a Form 8-K on December 2, 2003, reporting an amendment to its Shareholder Rights Agreement. The primary purpose of this amendment was to change the Final Expiration Date of the agreement from its original term to December 31, 2003. This action is a procedural update concerning corporate governance mechanisms and does not appear to reflect any immediate operational changes or significant financial events impacting the company's performance at this specific time. Investors should note that this filing primarily concerns the administrative extension of a previously established rights agreement. While such agreements are common for protecting shareholder value from hostile takeovers, the near-term expiration date suggests a review or conclusion of this particular arrangement. Further details would be found within the referenced Amendment No. 1 to the Rights Agreement.

Key Highlights

  • 1Amendment to Shareholder Rights Agreement executed on December 2, 2003.
  • 2The amendment changes the Final Expiration Date of the Rights Agreement.
  • 3The new Final Expiration Date is set for December 31, 2003.
  • 4The amendment is with Mellon Investor Services LLC, successor to ChaseMellon Shareholder Services L.L.C.
  • 5The original Rights Agreement was entered into on October 6, 1997.
  • 6This filing is classified under 'Other Events and Regulation FD Disclosure' (Item 5).
  • 7Exhibit 99 contains the full text of Amendment No. 1 to the Rights Agreement.

Frequently Asked Questions

The main purpose of this 8-K filing is to report an amendment to Pfizer's Shareholder Rights Agreement, specifically changing its Final Expiration Date.

A Shareholder Rights Agreement, often called a 'poison pill', is a defense tactic used by a corporation to prevent or deter hostile takeover attempts. This amendment likely extends or modifies the duration of this existing agreement, with the new expiration date being December 31, 2003.

This filing primarily concerns a procedural update to a corporate governance agreement. While the agreement is designed to protect against hostile takeovers, the amendment itself, setting a near-term expiration, does not inherently signal an immediate takeover threat or significant financial event. It's more likely an administrative adjustment or a move towards letting the agreement expire.

More details about the amendment can be found in Exhibit 99, which is 'Amendment No. 1 dated December 2, 2003, to the Rights Agreement dated October 6, 1997 between Pfizer Inc. and Mellon Investor Services LLC'.